Thus, the effective adjuvant therapies need to treat HCC and to prevent the recurrence. Cell-based therapy led to the development of a novel strategy for delivering therapeutic genes
efficacy of other cancer immunotherapeutic modalities, such as immune checkpoint blockade or adoptive cell-based therapy pre-clinically. Our study has launched a new avenue of cancer immunotherapy which
Background:The development of pluripotent stem cell-based strategies for regenerative medicine offers hope of one day having a limitless source of therapeutic cells for the repairing of damaged cardiac
drugs, natural compounds, and synthetic molecules using induced pluripotent stem cells (iPS) or other cell-based models of human diseases; (2) to be a service center for standardized drug
degradation of neurocan by ADAMTS-12 in neuropathies through the use of cell-based models and the phenotypic characterization of the ADAMTS-12 deficient mouse
conclusion, these findings may significantly impact on cardiovascular and neurodegenerative diseases, cancer, stem cell-based therapies and many other diseases, and may stimulate the development of new pharmacological…
Human cell-based models can provide important information on exposure and risk from chemical contaminants. Measurement of the amount of chemical contaminant entering the cells and how effectively
disruption of communication between the brain to the body. To treat such an injury, cell-based therapy has shown promising results, and the following papers are recommended. This communication will
mesenchymal stem cells from human bone marrow (ahMSCs) are a great promise for cell-based therapies by their ability to differentiate into osteoblast in certain microenvironments. The purpose of this
Cell-based therapy has emerged as a promising new treatment for cardiovascular diseases. One of the main obstacles to this approach is a limited number of endothelial progenitor cells (EPCs
down-regulation represents a significant challenge for T cell-based immunotherapy. T cell epitopes associated with impaired peptide processing (TEIPP) constitute a novel category of immunogenic neo-antigens that
down-regulation represents a significant challenge for T cell-based immunotherapy. T cell epitopes associated with impaired peptide processing (TEIPP) constitute a novel category of immunogenic neo-antigens that
dental pulp represents a suitable alternative source of stem cells for the purpose of cell-based therapies in regenerative medicine. Spinal cord injuries at the cervical (neck) level result
degree of pluripotency, which was responsive to changes in culture conditions and may benefit cell-based therapies. Thus, mature white adipocytes may be a new cell source for tissue regeneration
animal´s behavior in an open field and marble burying test. In vitro cell-based assays in neuroblastoma NB69 cells were employed for evaluation of the antioxidant property of ayahuasca
Various cell-based therapies use the transplantation of ex vivo cultured chondrocytes or stem cells to support repair of cartilage defects. Cell expansion in vitro is required prior to transplantation
differentiated into keratocyte progenitor- like cells. Use of hTMSCs derived from neural crest in cell-based therapeutics as source for corneal tissue engineering may overcome the problems of keratoplasty such
Fluorescence assay. The active compounds have also been tested on HIV-1 replication in cell-based assays. Findings: Five of the isolated compounds inhibited IN activity with IC50 values
regulatory framework for regenerative medicinal products, 1) upgrading of directives for human stem cell-based clinical research to the Law concerning the Establishment of Safety of Regenerative Medicine Materials…
assay HAneutralizing antibodies. We further expressed HA on the surface of cells and performed cell-based immunofluorescence assays with selected monoclonal antibodies and compared them with data generated from
sprouting assays. The signaling pathways were also investigated by Western blotting and all the cell-based assays were used with or without pharmacological inhibitors of mitogen-activated protein kinase (MAPK
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.